ArticleFrontiers in oncology2022

Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review.

Yuchen Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.